BioCardia Announces FDA Approval for Groundbreaking Heart Failure Treatment
BioCardia, Inc., a prominent player in the development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, has recently announced a significant milestone. The U.S. Food and Drug Administration (FDA) has approved the Phase III clinical trial protocol for BioCardia’s CardiAMP autologous cell therapy. This therapy is designed for patients suffering from ischemic heart […]
Harnessing Mesenchymal Stem Cells for Cardiac Regeneration: A Leap Towards Mending Broken Hearts
Heart ailments are among the leading causes of mortality and morbidity worldwide. The spectrum of heart disease encompasses conditions like myocardial infarction (heart attack), ischemic heart disease, heart failure, and numerous others. While modern medicine has made significant strides in managing these conditions, the ability to fundamentally restore the damaged cardiac tissue remains largely unattained. […]
Unleashing Cardiac Stem Cells: Transforming Heart Health
Introduction Let’s dive into the incredible world of cardiac stem cells and their potential to transform the field of heart disease treatment. If you or a loved one are dealing with heart conditions, we understand the challenges you face, and we’re here to offer hope. Heart conditions can have a profound impact on individuals, affecting […]
BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies
SUNNYVALE, Calif., April 04, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of two patent grants related to enabling technologies for delivery of its investigational autologous and allogeneic cell therapies. The United States Patent Office issued BioCardia Patent […]
Exploring the Benefits of MSCT for IHD
Introduction Mesenchymal Stem Cell Therapy (MSCT) is a promising, yet still experimental form of treatment that has the potential to revolutionize the management of Ischemic Heart Disease (IHD). What are Mesenchymal Stem Cells Mesenchymal stem cells (MSCs) are a type of adult stem cell found in the body that can differentiate into several different types […]